Pharma Journalist 8887 posts 0 comments

Basilea Pharmaceutica Ltd, a commercial-stage biopharmaceutical company based in Allschwil, Switzerland, announced that it has been awarded a contract by the U.S. Biomedical Advanced…
Read More...

Harmony Biosciences Holdings, Inc. has released topline results from its Phase 3 RECONNECT Study evaluating ZYN002, a transdermal cannabidiol gel, in patients with Fragile X syndrome…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Inluriyo (imlunestrant, 200 mg tablets), a new oral treatment from Eli Lilly and Company, for adults with estrogen…
Read More...

Eli Lilly and Company announced that the European Commission has granted marketing authorization for Kisunla (donanemab) to treat adults with early symptomatic Alzheimer’s disease (AD),…
Read More...

Cellectar Biosciences, a late-stage clinical biopharmaceutical company specializing in cancer drug development, has entered into an agreement with Evestia Clinical to provide full…
Read More...

AstraZeneca and Daiichi Sankyo have announced that the U.S. Food and Drug Administration (FDA) has accepted their supplemental Biologics License Application (sBLA) for Enhertu…
Read More...

Sanofi Ventures has received an additional $625 million multi-year capital commitment from its parent company, Sanofi, increasing its total assets under management to over $1.4 billion.…
Read More...

Moderna, Inc. has officially opened its Moderna Innovation and Technology Centre (MITC) at the Harwell Science and Innovation Campus in Oxfordshire, UK. This new facility will…
Read More...

Merck and Siemens have signed a new Memorandum of Understanding (MoU) to deepen their strategic partnership aimed at accelerating digital transformation across the life science industry…
Read More...

TegMine Therapeutics, a biotech company specializing in precision oncology by targeting cancer-driving glycoproteins, has announced a strategic research and development collaboration…
Read More...